Crohn’s & Colitis Congress™
Tweet
Sessions
Speakers
Exhibitors
Floor Plan
Buzz
Speakers
Michael
Chiorean
Michael Chiorean
MD
Virginia Mason Hospital
Sessions :
P144 - ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
Home
Sessions
Speakers
Exhibitors
Floor Plan
Tweet
Login
|
Back to top
ChirpE